Compounders Research Compare

Clearmind Medicine Inc.(CMND)

Biotechnology · Vancouver, BC

$5.85-0.15 (-2.50%)

Delayed quote: Oct 6, 2026, 3:00 PM EDT

About Clearmind Medicine Inc.

Clearmind Medicine Inc. is a pre-clinical biopharmaceutical company dedicated to pioneering the development of novel psychedelic-based treatments. Their primary goal is to address a variety of mental health and addiction challenges that currently lack adequate solutions. The company's research targets conditions such as alcohol use disorder (including problematic binge drinking), various eating disorders (like binge eating), depression, and other compulsive or "binge" behaviors. Founded in 2017, the company initially operated under the name Cyntar Ventures Inc. before officially rebranding as Clearmind Medicine Inc. in March 2021. Its operations are headquartered in Vancouver, Canada.

Vancouver, BC

4 employees

www.clearmindmedicine.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Adi Zuloff-Shani

View full financials

EV/EBIT Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBIT ratio is N/A as of 2026-10-06T19:01:08.463Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:01:08.463Z.

Quote observation: 2026-10-06T19:00:06.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 1,086,310
Total debt · period ending 2026-07-31: 1,798,264
Cash · period ending 2026-07-31: 12,035,210
TTM operating income · period ending 2026-07-31: -8,864,895

FMP input reference: 003104a745df447911be4c5a9e680832c7b19445192e606e8359fbce1df4db86

EV/EBITDA|EV/Sales|Operating Income|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

CMND EV/EBIT Ratio Metrics

EV/EBIT RATIO

N/A

CMND Competitors' EV/EBIT Ratio

Clearmind Medicine Inc.

Current

Market Cap

$1.09M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Cellyan Biotechnology Co., Ltd

Market Cap

$1.11M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IM Cannabis Corp.

Market Cap

$1.13M

EV/EBIT Ratio

N/A

TTM Avg

10.71x

3Y Avg

10.71x

5Y Avg

10.71x

Aspire Biopharma Holdings, Inc.

Market Cap

$1.02M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Propanc Biopharma, Inc.

Market Cap

$1.15M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GlucoTrack, Inc.

Market Cap

$901902.00

EV/EBIT Ratio

N/A

TTM Avg

1487.85x

3Y Avg

7742.21x

5Y Avg

7742.21x

Sunshine Biopharma, Inc.

Market Cap

$858572.00

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Bluejay Diagnostics, Inc.

Market Cap

$848052.00

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Bone Biologics Corporation

Market Cap

$850879.00

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Artelo Biosciences, Inc.

Market Cap

$1.35M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
Clearmind Medicine Inc. (CMND)	$1.09M	N/A	N/A	N/A	N/A
Cellyan Biotechnology Co., Ltd (HKPD)vs ›	$1.11M	N/A	N/A	N/A	N/A
IM Cannabis Corp. (IMCC)vs ›	$1.13M	N/A	10.71x	10.71x	10.71x
Aspire Biopharma Holdings, Inc. (ASBP)vs ›	$1.02M	N/A	N/A	N/A	N/A
Propanc Biopharma, Inc. (PPCB)vs ›	$1.15M	N/A	N/A	N/A	N/A
GlucoTrack, Inc. (GCTK)vs ›	$901902.00	N/A	1487.85x	7742.21x	7742.21x
Sunshine Biopharma, Inc. (SBFM)vs ›	$858572.00	N/A	N/A	N/A	N/A
Bluejay Diagnostics, Inc. (BJDX)vs ›	$848052.00	N/A	N/A	N/A	N/A
Bone Biologics Corporation (BBLG)vs ›	$850879.00	N/A	N/A	N/A	N/A
Artelo Biosciences, Inc. (ARTL)vs ›	$1.35M	N/A	N/A	N/A	N/A

EV/EBIT Ratio Formula & Definition

EV/EBIT = Enterprise Value / EBIT (TTM)

Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/EBITDA EV/Sales Operating Income All Metrics